Related Experiment Video

Updated: May 23, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Colonization by Pneumocystis jirovecii and its role in disease

Alison Morris1, Karen A Norris

  • 1Departments of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. morrisa@upmc.edu

Clinical Microbiology Reviews
|April 12, 2012
PubMed

Insights

Pneumocystis pneumonia (PCP) still affects immunocompromised individuals, including those with HIV. Research is exploring new diagnostics, treatments, and potential vaccines for this opportunistic infection.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Pneumocystis pneumonia (PCP) incidence decreased with antiretroviral therapy but remains significant in HIV-infected and non-HIV-infected immunosuppressed populations.
  • PCP epidemiology has evolved due to HIV treatment, prevention strategies, and critical care advancements.
  • Increasing organ transplants and immunotherapies contribute to a rise in PCP among non-HIV-infected individuals.

Purpose of the Study:

  • To review current clinical and research topics concerning Pneumocystis and PCP.
  • To highlight emerging areas for future research in PCP diagnosis, treatment, and prevention.
  • To discuss the role of the immune response in PCP pathogenesis and potential therapeutic targets.

Main Methods:

  • This is a review article, synthesizing existing literature on Pneumocystis pneumonia.
  • It analyzes epidemiological shifts and current trends in patient populations.
  • It discusses ongoing investigations into diagnostic and therapeutic modalities.

Main Results:

  • PCP remains a critical opportunistic infection, particularly in evolving immunosuppressed patient groups.
  • The immune response plays a dual role in disease prevention and lung damage.
  • Colonization with Pneumocystis is gaining attention for its potential link to other lung diseases.

Conclusions:

  • Further research is needed for novel diagnostic and treatment strategies for PCP.
  • Understanding the immune response may lead to vaccine development or immunomodulatory therapies.
  • Investigating Pneumocystis colonization could offer insights into chronic lung diseases like COPD.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.